280 related articles for article (PubMed ID: 25988934)
1. Lack of protection against ebola virus from chloroquine in mice and hamsters.
Falzarano D; Safronetz D; Prescott J; Marzi A; Feldmann F; Feldmann H
Emerg Infect Dis; 2015 Jun; 21(6):1065-7. PubMed ID: 25988934
[TBL] [Abstract][Full Text] [Related]
2. Antiviral effect of ranpirnase against Ebola virus.
Hodge T; Draper K; Brasel T; Freiberg A; Squiquera L; Sidransky D; Sulley J; Taxman DJ
Antiviral Res; 2016 Aug; 132():210-8. PubMed ID: 27350309
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
Oestereich L; Lüdtke A; Wurr S; Rieger T; Muñoz-Fontela C; Günther S
Antiviral Res; 2014 May; 105():17-21. PubMed ID: 24583123
[TBL] [Abstract][Full Text] [Related]
4. Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo.
Ma J; Zhang X; Soloveva V; Warren T; Guo F; Wu S; Lu H; Guo J; Su Q; Shen H; Solon E; Comunale MA; Mehta A; Guo JT; Bavari S; Du Y; Block TM; Chang J
Antiviral Res; 2018 Feb; 150():112-122. PubMed ID: 29253498
[TBL] [Abstract][Full Text] [Related]
5. Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model.
Dowall SD; Bosworth A; Watson R; Bewley K; Taylor I; Rayner E; Hunter L; Pearson G; Easterbrook L; Pitman J; Hewson R; Carroll MW
J Gen Virol; 2015 Dec; 96(12):3484-3492. PubMed ID: 26459826
[TBL] [Abstract][Full Text] [Related]
6. Early control of viral load by favipiravir promotes survival to Ebola virus challenge and prevents cytokine storm in non-human primates.
Reynard S; Gloaguen E; Baillet N; Madelain V; Guedj J; Raoul H; de Lamballerie X; Mullaert J; Baize S
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009300. PubMed ID: 33780452
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of
Goyal S; Binnington B; McCarthy SDS; Desmaële D; Férrié L; Figadère B; Loiseau PM; Branch DR
F1000Res; 2020; 9():268. PubMed ID: 32528661
[TBL] [Abstract][Full Text] [Related]
8. Repurposing Quinacrine against Ebola Virus Infection
Lane TR; Comer JE; Freiberg AN; Madrid PB; Ekins S
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31307979
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin.
Covés-Datson EM; Dyall J; DeWald LE; King SR; Dube D; Legendre M; Nelson E; Drews KC; Gross R; Gerhardt DM; Torzewski L; Postnikova E; Liang JY; Ban B; Shetty J; Hensley LE; Jahrling PB; Olinger GG; White JM; Markovitz DM
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007595. PubMed ID: 31356611
[TBL] [Abstract][Full Text] [Related]
10. Development of treatment strategies to combat Ebola and Marburg viruses.
Paragas J; Geisbert TW
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):67-76. PubMed ID: 16441210
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic Efficacy of Quercetin 3-β-O-d-Glucoside against Ebola Virus Infection.
Qiu X; Kroeker A; He S; Kozak R; Audet J; Mbikay M; Chrétien M
Antimicrob Agents Chemother; 2016 Sep; 60(9):5182-8. PubMed ID: 27297486
[TBL] [Abstract][Full Text] [Related]
12. Post-exposure efficacy of oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model.
Smither SJ; Eastaugh LS; Steward JA; Nelson M; Lenk RP; Lever MS
Antiviral Res; 2014 Apr; 104():153-5. PubMed ID: 24462697
[TBL] [Abstract][Full Text] [Related]
13. Development of a broad-spectrum antiviral with activity against Ebola virus.
Aman MJ; Kinch MS; Warfield K; Warren T; Yunus A; Enterlein S; Stavale E; Wang P; Chang S; Tang Q; Porter K; Goldblatt M; Bavari S
Antiviral Res; 2009 Sep; 83(3):245-51. PubMed ID: 19523489
[TBL] [Abstract][Full Text] [Related]
14. The cyanobacterial lectin scytovirin displays potent in vitro and in vivo activity against Zaire Ebola virus.
Garrison AR; Giomarelli BG; Lear-Rooney CM; Saucedo CJ; Yellayi S; Krumpe LR; Rose M; Paragas J; Bray M; Olinger GG; McMahon JB; Huggins J; O'Keefe BR
Antiviral Res; 2014 Dec; 112():1-7. PubMed ID: 25265598
[TBL] [Abstract][Full Text] [Related]
15. The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection.
Wu W; Liu S
Curr Top Med Chem; 2017; 17(3):361-370. PubMed ID: 27572081
[TBL] [Abstract][Full Text] [Related]
16. HSPA5 is an essential host factor for Ebola virus infection.
Reid SP; Shurtleff AC; Costantino JA; Tritsch SR; Retterer C; Spurgers KB; Bavari S
Antiviral Res; 2014 Sep; 109():171-4. PubMed ID: 25017472
[TBL] [Abstract][Full Text] [Related]
17. Second generation of diazachrysenes: Protection of Ebola virus infected mice and mechanism of action.
Selaković Ž; Tran JP; Kota KP; Lazić M; Retterer C; Besch R; Panchal RG; Soloveva V; Sean VA; Jay WB; Pavić A; Verbić T; Vasiljević B; Kuehl K; Duplantier AJ; Bavari S; Mudhasani R; Šolaja BA
Eur J Med Chem; 2019 Jan; 162():32-50. PubMed ID: 30408747
[TBL] [Abstract][Full Text] [Related]
18. Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primates.
Madelain V; Duthey A; Mentré F; Jacquot F; Solas C; Lacarelle B; Vallvé A; Barron S; Barrot L; Mundweiler S; Thomas D; Carbonnelle C; Raoul H; de Lamballerie X; Guedj J
Antiviral Res; 2020 May; 177():104758. PubMed ID: 32135218
[TBL] [Abstract][Full Text] [Related]
19. Intracellular conversion and in vivo dose response of favipiravir (T-705) in rodents infected with Ebola virus.
Bixler SL; Bocan TM; Wells J; Wetzel KS; Van Tongeren SA; Garza NL; Donnelly G; Cazares LH; Soloveva V; Welch L; Epstein C; Liang LF; Giesing D; Lenk R; Bavari S; Warren TK
Antiviral Res; 2018 Mar; 151():50-54. PubMed ID: 29289664
[TBL] [Abstract][Full Text] [Related]
20. Antiviral Screening of Multiple Compounds against Ebola Virus.
Dowall SD; Bewley K; Watson RJ; Vasan SS; Ghosh C; Konai MM; Gausdal G; Lorens JB; Long J; Barclay W; Garcia-Dorival I; Hiscox J; Bosworth A; Taylor I; Easterbrook L; Pitman J; Summers S; Chan-Pensley J; Funnell S; Vipond J; Charlton S; Haldar J; Hewson R; Carroll MW
Viruses; 2016 Oct; 8(11):. PubMed ID: 27801778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
